Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
TH Open : Companion Journal to Thrombosis and Haemostasis|July 13, 2026
Normalization of Haemostasis in People with Haemophilia A: Expert Consensus on Unmet Needs and a Framework for Advancing Towards Health EquityCedric Hermans, Günter Auerswald, Ruben Berrueco, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2024
A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: The coreVWD initiativeElizabeth Clearfield, Benjamin Kim, Sarah Ford, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 26, 2021
Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experimentMichelle Witkop, George Morgan, Jamie O'Hara, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 19, 2021
Evaluation of the sexual health in people living with hemophiliaFederico Germini, Chatree Chai-Adisaksopha, Drashti Pete, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2021
Identified unmet needs and proposed solutions in mild-to-moderate haemophilia: A summary of opinions from a roundtable of haemophilia expertsChristopher Walsh, Lisa Boggio, Lanette Brown-Jones, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2021
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studiesMark W Skinner, Claude Négrier, Ido Paz-Priel, et al.
Research and Practice in Thrombosis and Haemostasis|May 24, 2021
Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes setErna C van Balen, Brian O'Mahony, Marjon H Cnossen, et al.
Journal of Thrombosis and Haemostasis : JTH|September 7, 2023
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1Brian O'Mahony, Amy L Dunn, Andrew D Leavitt, et al.
Pageof 8